Symantec Corporation (NASDAQ:SYMC) shares moved up 0.82% in last trading session and ended the day at $18.54. SYMC Gross Margin is 82.20% and its has a return on assets of 5.80%. Symantec Corporation (NASDAQ:SYMC) quarterly performance is 16.37%.
Symantec Corporation (NASDAQ:SYMC) declared a special dividend. Investors of record on Tuesday, March 8th will be paid a dividend of 4.00 per share on Tuesday, March 22nd. This represents a yield of 3.12%. The ex-dividend date of this dividend is Friday, March 4th.
Quanta Services, Inc. (NYSE:PWR) ended the last trading day at $22.46. Company weekly volatility is calculated as 1.66% and price to cash ratio as 27.86. Quanta Services, Inc. (NYSE:PWR) showed a weekly performance of 2.04%.
Quanta Services, Inc. (NYSE:PWR) announced that president and chief executive officer (CEO) Jim O’Neil, has stepped down as part of Quanta’s ongoing leadership succession planning. Quanta’s board of directors has named current chief operating officer (COO), Earl “Duke” Austin, Jr., to succeed Mr. O’Neil as president and CEO. Mr. Austin will retain his current title of COO in addition to president and CEO. Mr. O’Neil has also resigned from the board of directors, and the board has appointed Mr. Austin to fill that position. Mr. O’Neil will remain available to Mr. Austin and the company as part of this planned succession.
On 14 March, Dana Holding Corporation (NYSE:DAN) shares moved up 2.61% and was closed at $13.35. DAN EPS growth in last 5 year was 8.65%. Dana Holding Corporation (NYSE:DAN) year to date (YTD) performance is -3.26%.
Dana Holding Corporation (NYSE:DAN) announced that Jonathan Collins has been named senior vice president and chief financial officer, effective March 28. Mr. Collins joins the company after serving in the same role at ProQuest, a global leader in information resources, following previous experience in the automotive-supply industry.
Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) shares decreased -7.01% in last trading session and ended the day at $4.42. GLMD has a return on assets of -31.80%. Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) quarterly performance is -46.03%.
On 7 March, Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) announced that it has randomized the first patient in the ARRIVE Study (ARamcholTM for the Reversal of HIV-AssociatEd Lipodystrophy and NAFLD), a proof-of-concept clinical trial that will evaluate the safety and efficacy of AramacholTM in up to 50 patients with HIV-associated lipodystrophy and nonalcoholic fatty liver disease, or NAFLD.
Caladrius Biosciences, Inc. (NASDAQ:CLBS) caters to the Healthcare space. Its weekly performance is 61.05%. On the last day of trading company shares ended up at $0.95. Caladrius Biosciences, Inc. (NASDAQ:CLBS) distance from 50-day simple moving average (SMA50) is 1.67%.
Caladrius Biosciences, Inc. (NASDAQ:CLBS) announces that the Company will release financial results for the fourth quarter and full year of 2015 after the U.S. financial markets close on Tuesday, March 15, 2016.
Leave a Reply